Molecular Insight Pharmaceuticals Overview

  • Founded
  • 1998
Founded
  • Status
  • Acquired/​Merged
  • Employees
  • 71
Employees
  • Latest Deal Type
  • M&A
  • Financing Rounds
  • 6

Molecular Insight Pharmaceuticals General Information

Description

Developer of small-molecule chemistry platform to significantly impact the care of men with prostate cancer. The company offers clinical stage specialty that are focused on critical unmet diagnostic and therapeutic needs of the prostate cancer patient.

Contact Information

Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Corporate Backed or Acquired
Primary Industry
Pharmaceuticals
Other Industries
Drug Discovery
Parent Company
Primary Office
  • 160 Second Street
  • Cambridge, MA 02142
  • United States
+1 (617) 000-0000
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Molecular Insight Pharmaceuticals Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Molecular Insight Pharmaceuticals‘s full profile, request access.

Request a free trial

Molecular Insight Pharmaceuticals Executive Team (10)

Name Title Board Seat Contact Info
Nelson Stacks Chief Executive Officer & Director
David Barlow Chief Executive Officer & Chairman of Board
John Babich Ph.D Chief Scientific Officer & President
Andrew Hilgenbrink Director
Barry Frankel Director
You’re viewing 5 of 10 executive team members. Get the full list »

Molecular Insight Pharmaceuticals Board Members (4)

Name Representing Role Since
00000 000000 Molecular Insight Pharmaceuticals Chief Executive Officer & Chairman of Board 000 0000
000000 000000 Self Board Member 000 0000
000000 000000000 00 Self Board Member 000 0000
To view Molecular Insight Pharmaceuticals’s complete board members history, request access »

Molecular Insight Pharmaceuticals Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Molecular Insight Pharmaceuticals Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Molecular Insight Pharmaceuticals‘s full profile, request access.

Request a free trial